south korea

Showing 15 posts of 15 posts found.

South Korea orders 46 million more Novavax and Pfizer COVID-19 vaccines

February 16, 2021
Manufacturing and Production COVID, COVID-19, Novavax, Pfizer, Vaccine, south korea

South Korea has arranged deals with Novavax and Pfizer-BioNTech to buy enough COVID-19 vaccines for 23 million more people.


South Korea secures enough COVID-19 vaccine doses for 44 million citizens

December 8, 2020
Manufacturing and Production, Sales and Marketing COVID-19, Vaccine, south korea

The South Korean Government has announced plans to secure enough COVID-19 vaccine doses to inoculate 44 million of its citizens, …


India and South Korea approve Gilead’s remdesivir for emergency use against COVID-19

June 3, 2020
Research and Development, Sales and Marketing COVID-19, Gilead, India, coronavirus, remdesivir, south korea

India and South Korea have moved to follow in the footsteps of the US in approving Gilead’s antiviral therapy remdesivir …


South Korea says Ebola drug remdesivir may not be suitable for all coronavirus patients

May 6, 2020
Research and Development COVID-19, coronavirus, south korea

South Korea says that remdesivir, traditionally used in treating Ebola, may not be effective enough in treating COVID-19 patients. South …


South Korea jails executives for their role in Samsung Biologics fraud

December 10, 2019
Manufacturing and Production Samsung phones, Sanofi, Sanofi Diabetes, South Korea Healthcare System, South Korea Samsung, diabetes, inhaled insulin, insulin, south korea

Three executives of Samsung Electronics have been sentenced to jail for their role in committing fraud at its biotech affiliate …


Singapore and South Korea agree to cooperate on Good Manufacturing Practice

November 26, 2019
Manufacturing and Production ASEAN, GMP, North Korea, ROK, Singapore, south korea

At a joint summit on Saturday, South Korea’s Ministry of Food and Drug Safety signed a memorandum of understanding (MOU) …


Samsung BioLogics delisted over accounting violations

November 14, 2018
Research and Development Business, Samsung, Samsung BioLogics, accounting, south korea

South Korean firm Samsung BioLogics has been delisted from the South Korean stock exchange. The decision has come after the …


J&J buy global rights to Yuhan’s lazertinib in deal worth $1.2bn

November 6, 2018
Manufacturing and Production J&J, JJ, NSCLC, Yuhan, deal, lazertinib, south korea

Johnson & Johnson’s Janssen Biotech unit has bought the rights to Yuhan’s third-generation EGFR tyrosine kinase inhibitor (TKI) lazertinib in a deal …


Samsung BioLogics’ shares down $6bn after accounting furore

May 2, 2018
Research and Development, Sales and Marketing Samsung BioLogics, Samsung Bioepis, biotech, drugs, pharma, pharmaceutical, south korea

Samsung BioLogics’ shares have been hit hard, after the South Korean company was handed a notice of suspected breach of …


J&J offers $134,000 grant to find the best start-up in South Korea

August 31, 2017
Research and Development J&J. pharma, Johnson & Johnson, drugs, life sciences, medicine, pharmaceutical, south korea

Johnson & Johnson is doubling down its efforts to grow its business in East Asia by identifying and recruiting promising …


South Korea fines Novartis over kickbacks scandal

March 2, 2017
Medical Communications, Sales and Marketing Kickback, Novartis, south korea

South Korea’s Ministry of Food and Drug Safety has fined Novartis 200 million won ($174,936) over the payment of kickbacks …


South Korea’s workforce expands 27% in last four years

November 7, 2016
Manufacturing and Production, Sales and Marketing Employment, manufacturing, production, south korea

South Korea’s pharmaceutical workforce has expanded by 27% in the last four years. The growth in jobs is can be …


Hanmi Pharmaceutical raided over insider trading suspicions

October 17, 2016
Sales and Marketing Boehringer Ingelheim, Genentech, Hanmi Pharmaceutical, south korea

At the end of September, we reported on a busy 24-hour for Hanmi Pharmaceutical, as they secured a deal with …


Hanmi Pharma shares crash after shock contract termination

September 30, 2016
Manufacturing and Production, Medical Communications, Research and Development Boehringer Ingelheim, Genentech, Germany, HM61713, Hanmi Pharmaceutical, Tagrisso, south korea

News broke on 29 September that Hanmi Pharma, South Korea’s leading drug maker, had signed a $910 million deal with …

Novartis admits employees gave kickbacks to doctors in South Korea

August 12, 2016
Medical Communications, Research and Development Novartis, kickbacks, south korea

Novartis has confirmed that six employees in South Korea gave kickbacks to doctors, as the current and former employees face …

Latest content